Ms. Lauren Herzog, M.S. CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 610 Dutchmans Ln, Easton, MD 21601 Phone: 410-822-4000 |
Rebecca Lynn Pertain, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 Fax: 410-228-0767 |
Jacalyn Baxendale, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 29000 Information Ln Ste 507, Easton, MD 21601 Phone: 410-822-2213 |
Mrs. Amybeth Podrasky Hellman, MS,CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 Fax: 410-820-0003 |
Aileen Plough, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 Magnolia St, Easton, MD 21601 Phone: 410-822-0330 |
Wendy M Kirby, MSCCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 |
Kathryn M Flynn, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 Fax: 410-228-0767 |
News Archive
Most people who meet a new acquaintance, or merely pass someone on the street, need only a glance to categorize that person as a particular race. But, sociologist Asia Friedman wondered, what can we learn about that automatic visual processing from people who are unable to see? Friedman, an assistant professor of sociology at the University of Delaware, set out to explore that question by interviewing 25 individuals who are blind. She will present her findings in a study at the 110th Annual Meeting of the American Sociological Association.
A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.
A safer and more sensitive contrast dye for MRI tests developed by a team led by Georgia State University researchers may provide the first effective, noninvasive method for detecting and diagnosing early-stage liver diseases, including liver fibrosis.
StemCellRegenMed, Inc. announces that a new stem cell gene and enzyme replacement treatment has been performed on a fourteen month old child with Tay-Sachs disease on November 2, 2010. Tay-Sachs is a devastating disease that afflicts children primarily of parents of Jewish heritage and in very rare cases families of Eastern European background and the Cajun region in the U.S.A.
Salk Institute scientists recently have developed a method to make micro brain structures in the lab. These microbrain tissues are designated to be used in research for treatment of neurological diseases such as Alzheimer's disease or Parkinson's disease.
› Verified 9 days ago